U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07003321) titled 'A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer' on May 26.
Brief Summary: The study is being conducted to evaluate the efficacy, safety, and ORR of HRS-4508 in subjects with locally advanced or metastatic non-small cell lung cancer; Evaluate the pharmacokinetic (PK) characteristics of HRS-4508 and other efficacy endpoints for the treatment of locally advanced or metastatic non-small cell lung cancer.
Study Start Date: June, 2025
Study Type: INTERVENTIONAL
Condition:
Solid Tumor
Intervention:
DRUG: HRS-4508 tablet
HRS-4508 tablet
Recruitment Status: NOT_YET_RECRUITING
Sponsor: J...